Home  >  News
Msc_Jun22 Advertisement
you can get e-magazine links on WhatsApp. Click here
  Taiwan FDA grants emergency use authorization to Novavax' Nuvaxovid Covid-19 vaccine for use in individuals aged 18 and over,   June 25, 2022
  Soligenix announces successful protection using a bivalent thermostabilized filovirus vaccine,   June 24, 2022
  Physicians and pharmacists would tell CDC to recommend vaccine like Fluzone High-Dose Quadrivalent for people 65 years and older: Surevey,   June 24, 2022
  CDC’s ACIP unanimously votes to provisionally recommend use of Merck’s Vaxneuvance as an option for pneumococcal vaccination in infants and children,   June 24, 2022
  Moderna to open vaccine research and manufacturing centre in UK,   June 23, 2022
  Merck’s pneumococcal 15-valent conjugate vaccine, Vaxneuvance gets US FDA approval to include children 6 weeks through 17 years of age,   June 23, 2022
  AmerisourceBergen Foundation commits $150,000 to equitable vaccination efforts across the globe,   June 20, 2022
  2022 Tang Prize in Biopharmaceutical Science honours 3 scientists for developing Covid-19 mRNA vaccines,   June 20, 2022
  US FDA grants emergency use authorization to Moderna’s Covid-19 vaccine for children 6 months of age and older,   June 20, 2022
  EMA initiates rolling review of Pfizer & BioNTech’s variant-adapted version of Covid-19 vaccine,   June 17, 2022
  Nordic, Roche strengthen collaboration for development of biomarkers for chronic diseases,   June 17, 2022
  Covaxin booster dose is effective against Covid-19's Delta, Omicron variants, says ICMR study,   June 16, 2022
  Australian TGA grants provisional registration to Novavax’s Nuvaxovid Covid-19 vaccine as booster in individuals aged 18 and over,   June 14, 2022
  Bavarian Nordic gets additional order from BARDA for 500,000 doses of Jynneos smallpox and monkeypox vaccine,   June 13, 2022
  Sinovac receives WHO prequalification for Poliomyelitis Vaccine,   June 10, 2022
  Bavarian Nordic inks agreement with Government of Canada to supply Imvamune smallpox vaccine,   June 08, 2022
  US FDA approves GSK’s Priorix for prevention of measles, mumps and rubella in individuals 12 months of age and older,   June 07, 2022
  WHO issues updated influenza vaccines position paper,   June 03, 2022
  Sandoz launches new global ‘Act4Biosimilars’ initiative, to improve patient access and increase adoption by at least 30% in 30+ countries by 2030,   June 01, 2022
  Takeda to transfer marketing authorization for Spikevax Covid-19 vaccine in Japan to Moderna,   June 01, 2022

Copyright © 2016 Saffron Media Pvt. Ltd |